SHOP APOTHEKE EUROPE N.V.

  • WKN: A2AR94
  • ISIN: NL0012044747
  • Land: Niederlande

Nachricht vom 19.03.2020 | 15:50

SHOP APOTHEKE EUROPE N.V. PUBLISHES AGENDA ANNUAL GENERAL MEETING OF SHAREHOLDERS 2020

DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): AGM/EGM
19.03.2020 / 15:50
The issuer is solely responsible for the content of this announcement.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE USA, CANADA, AUSTRALIA OR JAPAN.

SHOP APOTHEKE EUROPE N.V. PUBLISHES AGENDA ANNUAL GENERAL MEETING OF SHAREHOLDERS 2020

Venlo, 19 March 2020. SHOP APOTHEKE EUROPE N.V. ("SHOP APOTHEKE EUROPE" or the "Company") has today published the agenda for the annual general meeting of shareholders of the Company (the "AGM"). Based on today's risk assessment, the Company has convened the AGM and plans to hold the AGM on 30 April 2020. However, due to possible further developments with respect to the Covid-19 outbreak, the Company will continuously assess the risk situation, taking into account the assessments of the responsible authorities, and may decide on any further measures in relation to the AGM. We will keep you informed about further developments on our website.

The convocation announcement and the agenda, the accompanying explanatory notes and other information and documentation are available on the corporate website of the Company (http://shop-apotheke-europe.com) under Investor Relations / General Meeting / Annual General Meeting 2020 and via the link:

http://shop-apotheke-europe.com/en/investorrelations/hauptversammlung/

The AGM is scheduled to take place on Thursday, 30 April 2020, starting at 10:00 CEST at Bilderberg Chateau Holtmuhle, Kasteellaan 10, 5932 AG, Tegelen, The Netherlands.

SHOP APOTHEKE EUROPE gives top priority to the health of its employees, shareholders and other stakeholders when holding the AGM. Normally, the Company's managing board would of course be pleased that you attend the AGM in person. However, today, the Company urges all its shareholders to carefully consider whether they wish to attend the AGM in person this year in view of possible health risks relating to the Covid-19 outbreak.

Against this background, the Company strongly encourages its shareholders to take part in the AGM this year by way of proxy voting and not to attend the AGM in person. This way, the physical meeting can take place with only a limited number of core attendees and health risks for those attendees can be limited as much as possible.

Shareholders who are entitled to attend the AGM, and who choose to be represented and to cast their votes by proxy, can follow the meeting via webcast on 30 April 2020. In addition, those shareholders can ask questions in advance of the AGM. Please refer to Section 3 (General Information) of the convocation announcement for further details regarding the proxy voting option, how to follow the meeting via the webcast and how to ask questions in advance of the AGM.

SHOP APOTHEKE EUROPE strives to take the best measures possible in view of the Covid-19 outbreak, while limiting interruption to its business (including the AGM) as much as possible. The option of proxy voting is a good alternative to attendance in person, and enables all of our shareholders to cast their votes on the AGM voting items.

Furthermore, shareholders who wish to participate in the AGM are advised to check the AGM page on the Company's corporate website regularly to stay informed about the latest developments.

For further information please contact us at:

Investor Relations:
Rens Jan Kramer
Telephone: +31 77 850 6672
Email: rensjan.kramer@shop-apotheke.com

Trade and public media:
Sven Schirmer
Mobile: +49 152 28 50 63 61
Email: presse@shop-apotheke.com

Financial media:
Thomas Schnorrenberg
Mobile: +49 151 46 53 13 17
Email: presse@shop-apotheke.com



19.03.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Interview im Fokus

Mountain Alliance: „Großer Digitalisierungsschub“

Furioses Börsendebüt für den Datenbankspezialisten Exasol. Einer der Profiteure: Die Münchner Beteiligungsgesellschaft Mountain Alliance AG (MA, ISIN DE000A12UK08), die auch nach einem Teilexit noch rund 2% an Exasol hält. Aktuell notiert die MA-Aktie rund 30 % unter dem NAV. Financial.de sprach mit MA-CEO Daniel Wild über die stärksten Digitalisierungstrends, die kritische Größe von 100 Mio. Euro Börsenwert, den neuen Investor und weitere Aktienkäufe.

GBC-Fokusbox

Aves One AG: Kursziel 13,60 €

Die Aves One AG ist auch in der Corona-Krise als Bestandshalter von langlebigen Logistik-Assets mit langfristigen Mietverträgen gut aufgestellt. Das Unternehmen hat als Guidance einen Umsatz und ein EBITDA mindestens auf Vorjahresniveau verkündet. Unseres Erachtens sollte dies auch ohne Zukäufe gut machbar sein, da die im abgelaufenen Geschäftsjahr 2019 erworbenen Assets bereits zu einer höheren Umsatzbasis führen sollten. Auf Basis unseres DCF-Modells haben wir ein Kursziel in Höhe von 13,60 € ermittelt und vergeben ein KAUFEN-Rating.

News im Fokus

Deutsche Lufthansa AG: Einigung über Lufthansa Stabilisierungspaket

30. Mai 2020, 00:04

Aktuelle Research-Studie

2G Energy AG

Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Hinzufügen

29. Mai 2020